Gene expression construct of hap1 adapted for plant cells
CA 2460632 A1 · Owner: Laplaze, Laurent · Inventors: Runions, John; Hodge, Sarah; Bauch, Marion
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Provided are novel nucleic acid molecule encoding modified HAP1 DNA-binding domains. Also provided are novel reporter genes based on GFP and extension. The materials provided by the invention may be used in a variety of methods of activating genes having HAP1 upstream activation sequences in plants which , methods can be used to co-ordinate or investigate gene expression optionally , in conjunction with GAL4-regulated expression and also in novel "enhancer" , traps.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 20, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 20, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 20, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.